1-866-529-0001

 

New Drug for Mesothelioma

PDF Correo electrónico
There are no translations available.

The FDA recently approved a new drug used to treat malignant pleural mesothelioma, a rare cancer usually associated with asbestos exposure. The drug is called Alimta, or pemetrexed disodium, and it's distributed by Eli Lilly and Company. Alimta is intended to be used along with cisplatin.

Only about 2,000 new cases of mesothelioma are diagnosed each year in the U.S. Patients live, on average, nine to thirteen months after diagnosis.

In a randomized clinical trial, patients receiving Alimta along with cisplatin lived an average of 12 months after the trial began, compared with nine months for those on cisplatin alone.

Alimta must be supplemented with vitamin B-12 and folic acid to decrease the incidence and severity of adverse effects. Those effects include low white blood count, nausea, vomiting, fatigue, rash and diarrhea. Since the drug suppresses the bone marrow, patients are warned to report signs of infection, such as fever and chills.

Additional Information:

FDA Drug Information Page - Alimta (pemetrexed for injection).
http://www.fda.gov/cder/drug/infopage/alimta/default.htm

 

Asbestos Exposure Hotspots

FREE SUPPORT BOOKS

Get a FREE copy of Lean on Me or 100 Questions & Answers About Mesothelioma Read More.

FREE SOCIAL SECURITY HELP

We offer free help with obtaining social security disability for those diagnosed with certain asbestos-related diseases. Expedited Social Security benefits may be available to some of those affected by asbestos illnesses.
Read More

FREE VA CLAIM HELP

We often offer FREE help with your VA (Veterans Administration) claim. Read More

Quick Call Back

Free Case Review

Mulligan Family Foundation

The Mulligan Family Foundation was established by Patrick J. Mulligan to support kids in need throughout the United States, and especially in California and Texas. For more information, click here.

 
 
Do You Have A Case?